Pharmaceutical Research

, Volume 12, Issue 10, pp 1545–1547

Poly(D,L-Lactide) Nanocapsules Containing Non-Steroidal Anti-Inflammatory Drugs: Gastrointestinal Tolerance Following Intravenous and Oral Administration

  • Silvia Stanisçuaski Guterres
  • Hatem Fessi
  • Gillian Barratt
  • Francis Puisieux
  • Jean-Philippe Devissaguet
diclofenac indomethacin nanocapsules poly(D,L-Lactide) gastrointestinal tolerance intravenous oral 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    P. A. Todd and E. M. Sorkin. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs, 35: 244–285 (1988).Google Scholar
  2. 2.
    A. J. Collins and L. J. Notorianni. The acute action of fenbufen and piroxicam on the gastric mucosa as measured by gastric microbleeding. J. Int. Med. Res., 12: 179–183 (1984).Google Scholar
  3. 3.
    J. W. Fara and E. Myrback. Formulation and dosage form design in drug-induced topical irritation of the gastrointestinal tract. Pharm. Res., 7: 616–620 (1990).Google Scholar
  4. 4.
    E. C. Soehngen, E. Godin-Ostro, F. G. Fielder, R. S. Ginsberg, M. A. Slusher and A. L. Weiner. Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats. Arthritis and Rheumatism, 31: 412–421 (1989).Google Scholar
  5. 5.
    N. Ammoury, M. Dubrasquet, H. Fessi, J-P. Devissaguet, F. Puisieux and S. Benita. Indomethacin-loaded poly(D,L-lactide) nanocapsules: protection from gastrointestinal ulceration and antiinflammatory activity evaluation on rats. Clin. Mater., 13: 121–130 (1993).Google Scholar
  6. 6.
    S. S. Guterres, H. Fessi, G. Barratt, J-P. Devissaguet and F. Puisieux. Poly (D,L-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. Int. J. Pharm., 113: 57–63 (1995).Google Scholar
  7. 7.
    S. Bolton. Pharmaceutical Statistic—Practical and Clinical Applications. Marcel Dekker, New York (1984).Google Scholar
  8. 8.
    D. A. Brodie, P. G. Cook, J. Bauer and G. E Dagle. Indomethacin-induced intestinal lesions in the rats. Toxicol. Appl. Pharmacol., 17: 615–624 (1970).Google Scholar
  9. 9.
    K. J. Levy, D. B. Paone and W. J. Krause. Acute effect of systemic aspirin on gastric mucosa in man. Digestive Diseases and Sciences, 25: 97–99 (1980).Google Scholar
  10. 10.
    D. E. Duggan, K. F. Hooke, R. M. Noll and K. C. Kwan. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem. Pharmacol., 25: 1749–1754 (1975).Google Scholar
  11. 11.
    F. Fawaz, F. Bonini, M. Guyot, A. M. Lagueny, H. Fessi and J-P. Devissaguet. Influence of poly(D,L-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit. Pharm. Res., 10: 750–756 (1993).Google Scholar
  12. 12.
    V. Cioli, S. Putzolu, V. Rossi, P. Scorza-Barcellona and C. Corradino. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol. Appl. Pharmacol., 50: 283–289 (1979).Google Scholar
  13. 13.
    N. Ammoury, H. Fessi, J. P. Devissaguet, M. Dubrasquet and S. Benita. Jejunal absorption, pharmacological activity and pharmacokinetic evaluation of indomethacin loaded poly(D,L-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. Pharm. Res., 8: 101–105 (1991).Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • Silvia Stanisçuaski Guterres
  • Hatem Fessi
  • Gillian Barratt
  • Francis Puisieux
  • Jean-Philippe Devissaguet
    • 1
  1. 1.Laboratoire de Pharmacie Galénique et Biopharmacie, URA 1218Faculté de PharmacieChâtenay-MalabryFrance

Personalised recommendations